Clinical risks for development of the acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 151, Issue 2 I, 1995, Pages 293-301

  Hudson, Leonard D ^a   Milberg, John A ^b   Anardi, Doreen ^b   Maunder, Richard J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HUMAN; INJURY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT; RISK FACTOR; SEPSIS;

EID: 0028888644     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.151.2.7842182     Document Type: Article

References (40)

1. Brigham, K. L. 1990. Oxidant stress and adult respiratory distress syndrome. Eur. Respir. J. 3(Suppl 11):482s-484s.
2. Repine, J. E. 1992. Scientific perspectives on adult respiratory distress syndrome. Lancet 339:466-472.
3. Neuhof, H. 1991. Actions and interaction of mediator systems and mediators in the pathogenesis of ARDS and multiorgan failure. Acta. Anaesthesiol. Scand. 35(Suppl 95):7-14.
4. Pinsky, M. R., and G. M. Matuschak. 1989. Multiple systems organ failure: failure of host defense homeostasis. Crit. Care Clin. 5:199-220.
5. Swank, D. W., and S. B. Moore. 1989. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin. Proc. 64:1118-1132.
6. Wiener-Kronish, J. P., M. A. Gropper, and M. A. Matthay. 1990. The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment. Br. J. Anaesth. 65:107-129.
7. Cunningham, A. J. 1991. Acute respiratory distress syndrome - two decades later. Yale J. Biol. Med. 64:387-402.
8. Welbourn, C. R. B., and Y. Young. 1992. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br. J. Surg. 79:998-1003.
9. Martin, M. A., and H. J. Silverman. 1992. Gram-negative sepsis and the adult respiratory distress syndrome. Clin. Infect. Dis. 14:1213-1228.
10. Hatherill, J. R., and T. A. Raffin. 1989. Diagnosis and management of the adult respiratory distress syndrome. Compr. Ther. 15:21-27.
11. Mandell, G. L. 1988. ARDS, neutrophils, and pentoxifylline (editorial). Am. Rev. Respir. Dis. 138:1103-1105.
12. Maunder, R. J., and L. D. Hudson. 1990. Pharmacologic strategies for treating the adult respiratory distress syndrome. Respir. Care 35:241-246.
13. Goldstein, G., and J. M. Luce. 1990. Pharmacologic treatment of the adult respiratory distress syndrome. Clin. Chest Med. 11:773-787.
14. Pepe, P. E., R. T. Potkin, D. Holtman-Reus, L. D. Hudson, and C. J. Carrico. 1982. Clinical predictors of the adult respiratory distress syndrome. Am. J. Surg. 144:124-130.
15. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Bair, D. J. Eberle, T. L. Petty, and T. M. Hyers. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98:593-597.
16. Teasdale, and G., B. Jennett. 1974. Assessment of coma and impaired consciousness: a practical scale. Lancet 2:81-84.
17. Knaus, W. A. 1989. Epidemiology of multiple organ system failure. Crit. Care Clin. 5:100-107.
18. Baker, S. P., B. O'Neill, W. Hadden, and W. B. Long. 1974. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 14:187-196.
19. Selvin, S. 1991. Statistical analysis of epidemiologic data. New York: Oxford University Press, 310-338.
20. Rothman, K. 1986. Modern epidemiology. Boston: Little, Brown, 41-49.
21. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
22. Pepe, P. E., L. D. Hudson, and C. J. Carrico. 1984. Early application of positive end-expiratory pressure in patients at risk for the adult respiratory distress syndrome. N. Engl. J. Med. 311:281-286.
23. Meakins, J. L., B. Wicklund, R. A. Forse, and A. P. McLean. 1980. The surgical intensive care unit: current concepts in infection. Surg. Clin. North Am. 60:117.
24. The Veterans Administration Systemic Sepsis Cooperative Study Group. 1987. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317:659-665.
25. Bone, R. C., C. J. Fischer, Jr., T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk. 1987. A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317:653-658.
26. Bone, R. C., C. J. Fischer, Jr., T. P. Clemmer, G. J. Slotman, and C. A. Metz. 1987. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032-1036.
27. Luce, J. M., A. B. Montgomery, J. D. Marks, J. Turner, C. A. Metz, and J. F. Murray. 1988. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am. Rev. Respir. Dis. 138:62-68.
28. Sprung, C. L., P. V. Caralis, E. H. Marcial, M. Pierce, M. A. Gelbard, W. M. Long, R. C. Duncan, M. D. Tendler, and M. Karpf. 1984. The effects of high-dose corticosteroids in patients with septic shock: a prospective controlled study. N. Engl. J. Med. 311:1137-1143.
29. The ACCP/SCCM Consensus Conference Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655.
30. Kaplan, R. L., S. A. Sahn, and T. L. Petty. 1979. Incidence and outcome of the respiratory distress syndrome in gram negative sepsis. Arch. Intern. Med. 139:867-869.
31. Fein, A. M., M. Lippmann, H. Holtzman, A. Eliraz, and S. C. Goldberg. 1983. The risk factors, incidence and prognosis of ARDS following septicemia. Chest 83:40-42.
32. MacGregor, R. R. 1986. Alcohol and immune defense. J.A.M.A. 256: 1474-1479.
33. Dunne, F. J. 1989. Alcohol and the immune system: a causative agent in altering host defence mechanisms. Br. Med. J. 298:543-544.
34. Matuschak, G. M., and J. E. Rinaldo. 1988. Organ interactions in the adult respiratory distress syndrome during sepsis: Role of the liver in host defense. Chest 94:400-406.
35. Regensteiner, J. G., W. D. Woodard, and D. D. Hagerman. 1989. Combined effects of female hormones and metabolic rate on ventilatory drives in women. J. Appl. Physiol. 66:808-813.
36. Cotton, D. J., B. Seligmann, W. F. O'Brien, and J. I. Gallin. 1983. Selective defect in human neutrophil superoxide anion generation elicited by the chemoattractant N-formylmethionylleucylphenylalanine in pregnancy. J. Infect. Dis. 148:194-199.
37. Buyon, J. P., H. M. Korchak, and L. E. Rutherford. 1984. Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum. 27:623-630.
38. Fletcher, M. P., and B. Seligmann. 1986. PMN heterogeneity: long-term stability of fluorescent membrane potential responses to the chemoattractant N-formyl-methionyl-leucyl-phenylalanine in healthy adults and correlation with respiratory burst activity. Blood 68:611-618.
39. Klebanoff, S. J. 1977. Estrogen binding by leukocytes during phagocytosis. J. Exp. Med. 145:983-998.
40. Mitchell, D. R., J. A. Milberg, K. P. Steinberg, and L. D. Hudson. 1993. Trends in adult respiratory distress syndrome (ARDS) fatality rates from 1983 to 1992. Am. Rev. Respir. Dis. 147:A348.